Medical Communications

Showing 15 posts of 6408 posts found.

eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
ncri-harpal-hero

Cancer Research UK announces “largest ever” development investment

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK

Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …
happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …
actinium_pharma

Actinium snatches up ex-Novartis clinical manager

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actinium, Novartis, appointment

Actinium Pharmaceuticals has appointed Gregory Bergonio to the position of director of Clinical Operations, where he will first guide the …
ireena_vittal

Ireena Vittal joins Cipla executive board

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment

Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
cmglee_cambridge_cancer_research_web

UK oral cancer rates soar 68% over two decades

November 29, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …
shutterstock_57369385

Biosimilars and Generics: A no-brainer for treatment?

November 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
uday_baldota

Taro announces appointment of new CEO

November 25, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …
top_ten_1

Top Ten most popular articles on Pharmafile this week

November 25, 2016 Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …
deb_lancaster

Insider interview: Roche discusses efficacy of CDF and NICE

November 25, 2016 Medical Communications, Sales and Marketing CDF, NICE, Roche

Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …
nice_aerial

Lowered price wins NICE approval for Janssen leukaemia treatment

November 25, 2016 Medical Communications, Sales and Marketing Janssen, NICE, SMC, chronic lymphocytic leukaemia, ibrutinib, imbruvica

After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …
bristol

Opdivo first PD-1 inhibitor given European approval for haematological cancer

November 25, 2016 Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, PD1-Inhibitor, bristol myers-squibb

Bristol-Myers Squibb announced that it has received the first and only European approval for a PD1 inhibitor in the treatment …
celgene_1_02

NICE u-turns on Celgene’s drug for multiple myeloma

November 24, 2016 Medical Communications Celgene, NICE, imnovid

NICE has performed a U-turn on Celgene’s Imnovid (pomalidomide) based on new data and the offer of a price reduction. …
shutterstock_231613360

Non-small cell lung cancer market to hit $26bn by 2025

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …
The Gateway to Local Adoption Series

Latest content